首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Presence of immune infiltrates in early phases of prostate cancer: Establishment of a preclinical efficacy model to promote immunotherapy development

【24h】

Presence of immune infiltrates in early phases of prostate cancer: Establishment of a preclinical efficacy model to promote immunotherapy development

机译：前列腺癌早期阶段存在免疫浸润：建立临床前功效模型以促进免疫疗法的发展

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2016年第null期|共1页
作者
Suominen M. I.; Konkol Y.; Halleen J. M.; Bernoulli J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Presence of immune infiltrates in early phases of prostate cancer: Establishment of a preclinical efficacy model to promote immunotherapy development [J] . Suominen M. I., Konkol Y., Halleen J. M., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：前列腺癌早期阶段存在免疫浸润：建立临床前功效模型以促进免疫疗法的发展
2. Presence of immune infiltrates in early phases of prostate cancer: Establishment of a preclinical efficacy model to promote immunotherapy development [J] . Suominen M. I., Konkol Y., Halleen J. M., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：前列腺癌早期存在免疫渗透：建立促进免疫疗法发展的临床前疗效模型
3. Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Preclinical Models of Pancreatic Cancer [J] . Zhang Yuqing, Kirane Amanda, Huang Huocong, Molecular cancer research: MCR . 2019,第2期

机译：环氧氧酶-2抑制增强了血管内皮生长因子阻断的功效，并在胰腺癌的临床前模型中促进免疫刺激性微环境
4. Vaccine-Primed Lymph Node Cells In the Adoptive Immunotherapy of Cancer: Presence of Host Immune Suppression Induced by Established Cancer [C] . Shuang Wei, Andrew B. Shreiner, Alfred E. Chang International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：癌症的疫苗引发淋巴结细胞：癌症的存在免疫抑制因成立癌症诱导
5. Tumor Immunology: Understanding the Immune System and Cancer to Enhance the Efficacy of Cancer Immunotherapies [D] . Lenart, Natasha. 2020

机译：肿瘤免疫学：了解免疫系统和癌症，以提高癌症免疫治疗的疗效
6. Solution Formulation Development and Efficacy of MJC13 in a Preclinical Model of Castrate-Resistant Prostate Cancer [O] . Su Liang, Xiaomei Bian, Dong Liang, -1

机译：MJC13在去势抵抗性前列腺癌的临床前模型中的溶液配方开发和功效
7. Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Preclinical Models of Pancreatic Cancer [O] . Yuqing Zhang, Amanda Kirane, Huocong Huang, 2018

机译：环氧氧基酶-2抑制增强了血管内皮生长因子阻断的功效，并在胰腺癌的临床前模型中促进免疫刺激微环境
8. Formulated Delivery of Enzyme/Prodrug and Cytokine Gene Therapy to Promote Immune Reduction of Treated and Remote Tumors in Mouse Models of Prostate Cancer [R] . Russell, P. J. , Khatri, A. , Husaini, Y. , 2007

机译：配方递送酶/前药和细胞因子基因治疗促进小鼠前列腺癌模型中治疗和远程肿瘤的免疫减少

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号